In summary, our study endorses that the EGFR-mTORC2-RICTOR-AKT-UGCG-Ganglioside circuit regulates tumor progression in luminal breast cancer cells and provides us with an opportunity to intervene at multiple nodes to tame cancer cells. The gene discussed is EGFR; the disease is breast carcinoma.